The Power of Plant Callus Culture | VEMINSYN Donates 30 Rare Cloned Seedlings of Bletilla sinensis to the National Orchid Conservation Center

On August 7, 2024, Dr. Jiayue Chen, Co-founder of VEMINSYN, together with Dr. Zhou Yu, was invited to visit the National Orchid Conservation Center and attend a public welfare seminar focused on the conservation of Bletilla sinensis, an endangered plant species.

Bioactive Materials Innovation Platform——VEMINSYN Completes Nearly RMB 100 Million Series A Financing, Led by CITIC Capital.

As an emerging innovator in the field of biomanufacturing, VEMINSYN, a pioneering platform for novel bioactive materials, has recently announced the completion of its Series A financing round of nearly RMB 100 million.

VEMINSYN Secures Nearly 50 Million Yuan in Funding as It Applies Synthetic Biology to Medical Aesthetics and Skincare.

Medical aesthetics is a sector that combines high added value and strong rigid demand, where synthetic biology can demonstrate distinct technological advantages.